AGC Biologics A/S: Financial statements 2017
CVR: 25950941
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
AGC Biologics A/S (CVR 25950941) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 643,563,000 and a net result of DKK 74,528,000 compared with DKK 68,222,000 the year before. That is an increase of 23.3% compared with the year before. The profit margin was 11.6%. Equity in the 2017 report amounted to DKK 290,644,000. The solvency ratio was 57.9%. The company had 303 employees in the financial year.
- Revenue
- DKK 643,563,000
- Gross Profit
- DKK 156,786,000
- Profit/Loss
- DKK 74,528,000
- Equity
- DKK 290,644,000
- Total Assets
- DKK 501,574,000
- Employees
- 303
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 643.6M | 156.8M | 74.5M | 290.6M | 303 |
| 2016 | 521.8M | 116.1M | 68.2M | 216.1M | 245 |
| 2015 | 320.5M | 62.3M | 8.4M | 147.9M | 209 |
| 2014 | 311.1M | 45.8M | 3.2M | 139.5M | 199 |
| 2013 | - | 37.2M | -128K | 136.3M | 185 |
Official annual report
Keep an eye on AGC Biologics A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of June 30, 2017, Yukiteru Nakashita has joined the board of directors of AGC Biologics A/S.
As of June 30, 2017, Patricio Ezequiel Massera has left the board of directors of AGC Biologics A/S.
As of June 30, 2017, Kasper Møller is registered as director of AGC Biologics A/S.
As of June 30, 2017, Patricio Ezequiel Massera has stepped down as director of AGC Biologics A/S.
AGC Biologics A/S has published its annual report for 2016. Revenue came to DKK 521,795,000, and the net result was DKK 68,222,000.
As of May 31, 2017, KPMG P/S has been appointed auditor of AGC Biologics A/S.
As of May 31, 2017, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of AGC Biologics A/S.
As of February 1, 2017, Kasper Møller has joined the board of directors of AGC Biologics A/S.
As of February 1, 2017, Hideyuki Kurata has joined the board of directors of AGC Biologics A/S.
As of February 1, 2017, Ikuo Matsukura has joined the board of directors of AGC Biologics A/S.
About AGC Biologics A/S
AGC Biologics A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2001. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named CMC BIOLOGICS A/S and CMC BIOPHARMACEUTICALS A/S. The management consists of Kasper Møller. The board consists of Tadashi Murano (chair), Alberto Santagostino, Kasper Møller and Mai Iwaya. The company is owned by Asahi Glass Co., Ltd.. The company has 1,294 employees (2026). In 2025, the company reported revenue of DKK 1,959,639,000 and a net result of DKK -328,010,000 compared with DKK -115,005,000 the year before. Equity in the 2025 report amounted to DKK 312,021,000.